Conagra Brands crosses its fiscal Q1 2027 earnings line at $14.13 with shorts already on the retreat and the Street split between a structural reset and a recovery story that still needs proof.
The short position tells the most active story of the past week. SI fell 15% over the seven days to September 29, dropping from close to 9.7% of the free float to 8.2%. That move continues a trend flagged in earlier notes: bears have been trimming into the release rather than pressing. The monthly picture still shows a net build of around 10%, so the week's retreat gives back only part of a larger accumulation from August and early September. Borrow conditions give shorts no reason to rush. The cost to borrow has dropped 24% over the week to just 0.36%, and availability is at 4,560%, meaning the lending pool holds roughly 45 shares available for every one borrowed. There is no mechanical pressure on bears whatsoever. Options positioning is equally relaxed. The put/call ratio of 0.49 sits fractionally below its 20-day average and nearly 1.4 standard deviations below it, closer to the 52-week low of 0.45 than to any defensive extreme. Taken together, neither the lending market nor options pricing suggests the market was bracing for a shock.
The Street reflects the same ambivalence. The analyst consensus mean target is $14.44, barely above the current price of $14.13, implying less than 2% upside from a group that cannot agree on direction. Two firms raised targets in September: Evercore ISI lifted to $13 (from $12.50) on the day of results, and Deutsche Bank moved to $13 from $12 a fortnight earlier, both while holding neutral-equivalent ratings. Neither lift inspires confidence given the targets sit below the current price. Barclays remains the one firm with an Overweight, carrying a $17 target set in July. The bull case centres on new CEO Brase's restructuring agenda: the 50% dividend cut freeing roughly $335 million of annual cash earmarked for debt paydown, a zero-based SKU review, and supply chain investment that could ease gross margin pressure as unfavourable year-over-year comparisons roll off. The bear case is harder to dismiss right now. FY27 guidance implies adjusted EPS of $1.40 to $1.50, and the company has flagged roughly 5% to 6% COGS inflation, a $40 million tariff headwind, and a step-up in marketing spend to around 3% of net sales. Adjusted operating margin is guided to 10% to 10.5%, with Q1 expected to be the trough. Factor scores reinforce the caution: EPS momentum over 30 days ranks in the 23rd percentile, and EPS surprise is in just the 2nd percentile, reflecting a string of misses against expectations.
The ownership picture has one notable development. BlackRock raised its disclosed stake from 8.2% to 13.5% in a 13G/A filed in July, reaching 16.6% of shares held as of August 31 per the latest institutional data. That is a significant passive build but carries the standard caveat: 13D/G positions are event-driven disclosures around the 5% threshold, and the holding may have moved since the last filing. Vanguard entities collectively account for a further 11% of shares. There is no activist on the 13D register. Insider activity is similarly unremarkable; the only recent open-market equivalent is a small $26,000 director grant in early September, and the 90-day net from the EDGAR record nets to zero after stripping out the option exercises and tax-withholding transactions that dominated July activity.
The stock is down 12% over the past month and 4.4% on the week, underperforming close peers GIS (down 4.6% on the week) and HSY (down 4.2%), with CPB roughly flat. That peer weakness suggests some of the pressure is sector-wide rather than purely Conagra-specific, though CAG's drawdown is the steepest of the group. Valuation multiples give some context: the PE ratio has compressed by more than 1.1 turns over the past 30 days to 9.4x, while price-to-book has fallen 0.08 turns over the same period to 0.97x, meaning the stock now trades below book value. The EV/EBITDA multiple of 8.7x has moved little.
What to watch next is whether Q1 results, due imminently, confirm the company's own trough-quarter framing or push the operating margin floor lower than the 10% guided level, which would test whether the bear trade that is currently trimming has good reason to rebuild.
See the live data behind this article on ORTEX.
Open CAG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
